Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation
Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated. A consecutive cohort of DM/RI patients being assessed...
Gespeichert in:
Veröffentlicht in: | Transplantation 2011-01, Vol.91 (2), p.213-218 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 218 |
---|---|
container_issue | 2 |
container_start_page | 213 |
container_title | Transplantation |
container_volume | 91 |
creator | WELSH, Robert C COCKFIELD, Sandra M CAMPBELL, Patrica HERVAS-MALO, Marilou GYENES, Gabor DZAVIL, Vladamir |
description | Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated.
A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events.
Baseline characteristics (n = 280) are as follows: mean age 48.6 years (± 11.5 standard deviation), 66% men, diabetes duration 22.6 years (mean ± 8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98-17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (≥ 70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events.
DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted. |
doi_str_mv | 10.1097/TP.0b013e3181ff4f61 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_858420442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>843415702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-5836c252194b315e8b1b50d9e2131daff4367bb76ff89e8c6bbab8db3e0b7ffd3</originalsourceid><addsrcrecordid>eNqFkUFv1DAQhS0EotvCL0BCuSBOKTMZO_Yey1IKUiVWsJwj2xmjoGyyeLJI_HtcdQsSF05zeN-M3ryn1AuES4S1fbPbXkIAJCZ0mJJOLT5SKzSk6xYcPFYrAI01EtkzdS7yHQAMWftUnTUI2hnClYobn_th_uklHkefqysRFtnztFRzqt4NPvAyxOp66usvi__G1Wee_FgEYS9cbf0yFFaqt5zm_KDusp_kMPppKfI8PVNPkh-Fn5_mhfr6_nq3-VDffrr5uLm6raNGXGrjqI2NaXCtA6FhFzAY6NfcIGHvy4fU2hBsm5Jbs4ttCD64PhBDsCn1dKFe39895PnHkWXp9oNEHosRno_SOeN0A1o3_yc1aTQW7ki6J2OeRTKn7pCHvc-_OoTuroZut-3-raFsvTzdP4Y99392HnIvwKsTUIL3YyqBxUH-cmQdQTH6G8PokhU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>843415702</pqid></control><display><type>article</type><title>Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>WELSH, Robert C ; COCKFIELD, Sandra M ; CAMPBELL, Patrica ; HERVAS-MALO, Marilou ; GYENES, Gabor ; DZAVIL, Vladamir</creator><creatorcontrib>WELSH, Robert C ; COCKFIELD, Sandra M ; CAMPBELL, Patrica ; HERVAS-MALO, Marilou ; GYENES, Gabor ; DZAVIL, Vladamir</creatorcontrib><description>Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated.
A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events.
Baseline characteristics (n = 280) are as follows: mean age 48.6 years (± 11.5 standard deviation), 66% men, diabetes duration 22.6 years (mean ± 8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98-17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (≥ 70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events.
DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted.</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>DOI: 10.1097/TP.0b013e3181ff4f61</identifier><identifier>PMID: 21048531</identifier><identifier>CODEN: TRPLAU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Biological and medical sciences ; Cardiac Catheterization ; Cardiovascular Diseases - complications ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - physiopathology ; Cohort Studies ; Coronary Angiography ; Coronary Artery Disease - complications ; Coronary Artery Disease - diagnosis ; Coronary Artery Disease - physiopathology ; Diabetes Complications - diagnosis ; Diabetes Complications - physiopathology ; Diabetes. Impaired glucose tolerance ; Diabetic Nephropathies - complications ; Diabetic Nephropathies - physiopathology ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Humans ; Kidney Failure, Chronic - complications ; Kidney Failure, Chronic - physiopathology ; Kidney Transplantation ; Male ; Medical sciences ; Middle Aged ; Predictive Value of Tests ; Risk Factors ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Tissue, organ and graft immunology</subject><ispartof>Transplantation, 2011-01, Vol.91 (2), p.213-218</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-5836c252194b315e8b1b50d9e2131daff4367bb76ff89e8c6bbab8db3e0b7ffd3</citedby><cites>FETCH-LOGICAL-c411t-5836c252194b315e8b1b50d9e2131daff4367bb76ff89e8c6bbab8db3e0b7ffd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23783042$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21048531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WELSH, Robert C</creatorcontrib><creatorcontrib>COCKFIELD, Sandra M</creatorcontrib><creatorcontrib>CAMPBELL, Patrica</creatorcontrib><creatorcontrib>HERVAS-MALO, Marilou</creatorcontrib><creatorcontrib>GYENES, Gabor</creatorcontrib><creatorcontrib>DZAVIL, Vladamir</creatorcontrib><title>Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated.
A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events.
Baseline characteristics (n = 280) are as follows: mean age 48.6 years (± 11.5 standard deviation), 66% men, diabetes duration 22.6 years (mean ± 8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98-17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (≥ 70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events.
DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cardiac Catheterization</subject><subject>Cardiovascular Diseases - complications</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - physiopathology</subject><subject>Cohort Studies</subject><subject>Coronary Angiography</subject><subject>Coronary Artery Disease - complications</subject><subject>Coronary Artery Disease - diagnosis</subject><subject>Coronary Artery Disease - physiopathology</subject><subject>Diabetes Complications - diagnosis</subject><subject>Diabetes Complications - physiopathology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic Nephropathies - complications</subject><subject>Diabetic Nephropathies - physiopathology</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - complications</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Risk Factors</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Tissue, organ and graft immunology</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUFv1DAQhS0EotvCL0BCuSBOKTMZO_Yey1IKUiVWsJwj2xmjoGyyeLJI_HtcdQsSF05zeN-M3ryn1AuES4S1fbPbXkIAJCZ0mJJOLT5SKzSk6xYcPFYrAI01EtkzdS7yHQAMWftUnTUI2hnClYobn_th_uklHkefqysRFtnztFRzqt4NPvAyxOp66usvi__G1Wee_FgEYS9cbf0yFFaqt5zm_KDusp_kMPppKfI8PVNPkh-Fn5_mhfr6_nq3-VDffrr5uLm6raNGXGrjqI2NaXCtA6FhFzAY6NfcIGHvy4fU2hBsm5Jbs4ttCD64PhBDsCn1dKFe39895PnHkWXp9oNEHosRno_SOeN0A1o3_yc1aTQW7ki6J2OeRTKn7pCHvc-_OoTuroZut-3-raFsvTzdP4Y99392HnIvwKsTUIL3YyqBxUH-cmQdQTH6G8PokhU</recordid><startdate>20110127</startdate><enddate>20110127</enddate><creator>WELSH, Robert C</creator><creator>COCKFIELD, Sandra M</creator><creator>CAMPBELL, Patrica</creator><creator>HERVAS-MALO, Marilou</creator><creator>GYENES, Gabor</creator><creator>DZAVIL, Vladamir</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20110127</creationdate><title>Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation</title><author>WELSH, Robert C ; COCKFIELD, Sandra M ; CAMPBELL, Patrica ; HERVAS-MALO, Marilou ; GYENES, Gabor ; DZAVIL, Vladamir</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-5836c252194b315e8b1b50d9e2131daff4367bb76ff89e8c6bbab8db3e0b7ffd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cardiac Catheterization</topic><topic>Cardiovascular Diseases - complications</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - physiopathology</topic><topic>Cohort Studies</topic><topic>Coronary Angiography</topic><topic>Coronary Artery Disease - complications</topic><topic>Coronary Artery Disease - diagnosis</topic><topic>Coronary Artery Disease - physiopathology</topic><topic>Diabetes Complications - diagnosis</topic><topic>Diabetes Complications - physiopathology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic Nephropathies - complications</topic><topic>Diabetic Nephropathies - physiopathology</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - complications</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Risk Factors</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Tissue, organ and graft immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WELSH, Robert C</creatorcontrib><creatorcontrib>COCKFIELD, Sandra M</creatorcontrib><creatorcontrib>CAMPBELL, Patrica</creatorcontrib><creatorcontrib>HERVAS-MALO, Marilou</creatorcontrib><creatorcontrib>GYENES, Gabor</creatorcontrib><creatorcontrib>DZAVIL, Vladamir</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WELSH, Robert C</au><au>COCKFIELD, Sandra M</au><au>CAMPBELL, Patrica</au><au>HERVAS-MALO, Marilou</au><au>GYENES, Gabor</au><au>DZAVIL, Vladamir</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>2011-01-27</date><risdate>2011</risdate><volume>91</volume><issue>2</issue><spage>213</spage><epage>218</epage><pages>213-218</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><coden>TRPLAU</coden><abstract>Although consensus guidelines for preoperative cardiovascular (CV) assessment exist, diabetic patients with renal insufficiency (DM/RI) undergoing assessment for renal transplantation are a unique high-risk group that remains poorly investigated.
A consecutive cohort of DM/RI patients being assessed for renal transplantation was studied. We analyzed the ability of clinical characteristics and noninvasive investigation to predict significant coronary artery disease (CAD) and incidence of major adverse CV events.
Baseline characteristics (n = 280) are as follows: mean age 48.6 years (± 11.5 standard deviation), 66% men, diabetes duration 22.6 years (mean ± 8.9 standard deviation), 92% hypertension, 46% hypercholesterolemia, 24% family history CAD, and 21% known CAD. Abnormal myocardial perfusion imaging was found in 27.8%, and 56.5% had CAD more than or equal to 50%. Although positive myocardial perfusion imaging was the only independent predictor of CAD (odds ratio 7.18, 95% confidence interval 2.98-17.3), a poor negative predicted value was observed with normal imaging in 50.3% of patients having CAD more than or equal to 50%, 35.4% CAD more than 70%, and 41.8% Duke angiographic score more than or equal to 4. At mean follow up of 4 years (median 3.9), 76 of 280 patients suffered major adverse cardiovascular events including 17% mortality. Angiographic evidence of CAD (≥ 70% odds ratio 1.81, 95% confidence interval 1.02-3.23) was the only independent predictor of major adverse cardiac events.
DM/RI patients being assessed for renal transplantation have frequent CV risk factors, high likelihood of CAD, and a 28% incidence of major adverse cardiac events after 4 years. Myocardial perfusion imagining is of little clinical utility as a screening tool for CAD in this population. Only angiographic CAD was predictive of subsequent major adverse cardiac events. Further studies of risk stratification and revascularization in this high-risk population are warranted.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>21048531</pmid><doi>10.1097/TP.0b013e3181ff4f61</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1337 |
ispartof | Transplantation, 2011-01, Vol.91 (2), p.213-218 |
issn | 0041-1337 1534-6080 |
language | eng |
recordid | cdi_proquest_miscellaneous_858420442 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adult Biological and medical sciences Cardiac Catheterization Cardiovascular Diseases - complications Cardiovascular Diseases - diagnosis Cardiovascular Diseases - physiopathology Cohort Studies Coronary Angiography Coronary Artery Disease - complications Coronary Artery Disease - diagnosis Coronary Artery Disease - physiopathology Diabetes Complications - diagnosis Diabetes Complications - physiopathology Diabetes. Impaired glucose tolerance Diabetic Nephropathies - complications Diabetic Nephropathies - physiopathology Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - physiopathology Kidney Transplantation Male Medical sciences Middle Aged Predictive Value of Tests Risk Factors Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Tissue, organ and graft immunology |
title | Cardiovascular Assessment of Diabetic End-Stage Renal Disease Patients Before Renal Transplantation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A06%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20Assessment%20of%20Diabetic%20End-Stage%20Renal%20Disease%20Patients%20Before%20Renal%20Transplantation&rft.jtitle=Transplantation&rft.au=WELSH,%20Robert%20C&rft.date=2011-01-27&rft.volume=91&rft.issue=2&rft.spage=213&rft.epage=218&rft.pages=213-218&rft.issn=0041-1337&rft.eissn=1534-6080&rft.coden=TRPLAU&rft_id=info:doi/10.1097/TP.0b013e3181ff4f61&rft_dat=%3Cproquest_cross%3E843415702%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=843415702&rft_id=info:pmid/21048531&rfr_iscdi=true |